Secondary Myelofibrosis Completed Phase Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0030964 (Secondary Myelofibrosis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00445744Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeTreatment